跳至主要内容
临床试验/NCT04917640
NCT04917640撤回不适用

Accelerated Partial Breast Irradiation (PBI) With Stereotactic Body Radiation Therapy (SBRT) or Intensity Modulated Radiation Therapy (IMRT)

GenesisCare USA1 个研究点 分布在 1 个国家开始时间: 2021年6月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

研究概览

简要总结

This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Greater than or equal to 50 years old Low to intermediate DCIS Tumor size < or = to 2cm

排除标准

  • •BRCA positive Lobular histology Angiolymphatic invasion

结局指标

主要结局

Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

时间窗: Through study completion, an average of 12 months

Toxicity will be assessed using the CTCAEv4.0 and recorded.

次要结局

  • Number of participants with ipsilateral breast recurrence(Through study completion, an average of 12 months)

研究者

发起方
GenesisCare USA
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验